Genomic Heterogeneity Underlies Mixed Response to Tropomyosin Receptor Kinase Inhibition in Recurrent Glioma. Academic Article uri icon

Overview

publication date

  • August 8, 2018

Identity

PubMed Central ID

  • PMC6582975

Scopus Document Identifier

  • 85077486250

Digital Object Identifier (DOI)

  • 10.1200/PO.18.00089

PubMed ID

  • 31218270

Additional Document Info

volume

  • 2